Hunan Xinhui Pharmaceutical Co., Ltd. is a core leading enterprise established by Chairman and General Manager of Changsha Xinquan Xinlin Health Industry (Headquarters) Co., Ltd. In May 2002, based on the acquisition of the former state-owned bankrupt enterprise Hunan Xiangmin Pharmaceutical Factory It has been established and has produced more than 40 varieties of Houtou Jianweiling Tablets, Houtou Jianweiling Capsules, Shenjian Brain Liquid, Jiuwei Gantai Capsules, Snake Dan Chuanbei Loquat Paste for many years. Five production workshops, including pretreatment (including Chinese medicine extraction), solid preparations, liquid preparations, Chinese herbal medicine tablets, Chinese medicine formula granules, and modern comprehensive scientific research building, bioengineering center and pharmaceutical company, with a construction area of ​​more than 40,000 square meters. Equipped with six domestic professional dosage forms and six production lines, production and processing equipment for Chinese herbal medicines and Chinese herbal formula granules. The annual production capacity of preparations, Chinese herbal medicines and Chinese herbal formula granules is more than 1 billion yuan respectively. It is a collection of new drug development, Chinese herbal medicine preparations, Chinese herbal medicines, and Chinese herbal medicines. A modern high-tech pharmaceutical enterprise integrating the production and sales of formula granules, bioengineering products and health products.

The company unswervingly implements the innovation-driven strategy and implements management innovation and technological innovation alongside each other. First, the business philosophy of "producing safe drugs and being sincere to the people of the world" was laid. The "building of a integrity cultural management system for pharmaceutical enterprises" has been innovated, and the concept of integrity cultural inclusion in the entire value chain of pharmaceutical production and operation. Driven by the innovation strategy, the company has formed a 10,000-acre Chinese medicinal materials planting base with Xinhui Pharmaceutical Co., Ltd. as the core leading enterprise, and the entire traditional Chinese medicine industry chain and medicine for the production and sales of Chinese herbal medicine tablets, Chinese herbal formula granules, Chinese herbal preparations and health products. The mycelium raw material industry chain of dual-use biologically active substances has successfully achieved effective extension of the health industry.